Form 4: Outset Medical Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


John L. Brottem, General Counsel of Outset Medical, Inc., sold shares to cover tax withholding obligations related to vesting RSUs and acquired shares through the Employee Stock Purchase Plan.

Summary

  • On May 16, 2024, John L. Brottem, General Counsel of Outset Medical, Inc., sold 2,972 shares of common stock at a price of $3.53 per share.
  • The sale was executed to cover tax withholding obligations associated with the vesting of 5,887 shares of common stock underlying Restricted Stock Units (RSUs) granted on March 15, 2021, January 26, 2022, and January 6, 2023.
  • This transaction was a 'sell to cover' transaction and not a discretionary trade.
  • Brottem also acquired 1,801 shares of Common Stock pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (ESPP) for the purchase period of September 1, 2023 to February 29, 2024.
  • Following the reported transaction, Brottem beneficially owns 243,875 shares of Outset Medical, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The sale is for tax purposes, and the ESPP purchase is a positive sign, balancing each other out.

Positives

  • Brottem's participation in the ESPP indicates confidence in the company's future.

Industry Context

Executive stock transactions are common and are often related to compensation and tax planning. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

  • The sale of shares could have a minor, temporary impact on the stock price.
  • The ESPP participation benefits employees and aligns their interests with shareholders.

Key Dates

DateDescription
March 15, 2021Date of RSU grant to the reporting person.
January 26, 2022Date of RSU grant to the reporting person.
January 6, 2023Date of RSU grant to the reporting person.
September 1, 2023Start date of the Employee Stock Purchase Plan purchase period.
February 29, 2024End date of the Employee Stock Purchase Plan purchase period.
May 16, 2024Date of the stock sale transaction.
May 17, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.